Interesting topic-
Scoreboard- David started and the stock was at 85.50 (ceo tenure not including his other role as zimmer)
He concluded in 2017 when the stock was at 118.
Not exactly lights out but compared to Hanson, the bull,and bezajk it’s not even close.
Sales were 3.8 bil and when he took over and they were approximately 7.6 using 2016 numbers prior to his leaving in 2017.
He acquired Abbott spine, knee creations, and biomet, the largest merger in orthopedics history.
Maybe you didn’t like him but his track record isn’t even comparable to layoffs, horrible stock performance, moral at lows, and bringing on the bull and beighjak.
A thought to ponder.